Изучение эффективности применения симвастатина при остром ишемическом инсульте: акцент на эндотелиальную дисфункцию
А. Ю. Малыгин, И. Н. Каграманян, А. Л. Хохлов · Человек и его здоровье · 2013
The efficacy of Simvastatin (40 mg/day) therapy initiated in acute stage of ischemic stroke was evaluated in 12-month comparative randomized study. Simvastatin 40 mg/day prescribed along with neuroprotective and antihypertensive therapy in the acute stage of ischemic stroke leads to lowering the recurrent cardiovascular events, positive dynamics of neurological status, and the regression of the endothelial dysfunction, associated with the improved renal function.
Cited by 0 works.